OPEN END TURBO LONG - TWIST BIOSCIENCE Stock

Certificat

DE000ME4TYH6

Delayed Börse Stuttgart 03:49:15 2024-05-28 pm EDT
1.83 EUR -0.54% Intraday chart for OPEN END TURBO LONG - TWIST BIOSCIENCE
Current month+117.86%
1 month+120.48%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-28 1.83 -0.54%
24-05-24 1.84 +5.75%
24-05-23 1.74 -7.94%
24-05-22 1.89 -4.55%
24-05-21 1.98 -3.88%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 03:49 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying TWIST BIOSCIENCE CORPORATION
Issuer Morgan Stanley
WKN ME4TYH
ISINDE000ME4TYH6
Date issued 2023-12-06
Strike 23.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.56
Lowest since issue 0.28

Company Profile

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.
Sector
-
More about the company

Ratings for Twist Bioscience Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Consensus: Twist Bioscience Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
42.44 USD
Average target price
43.38 USD
Spread / Average Target
+2.20%
Consensus